Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 130Brain Neoplasms 115Prostatic Neoplasms 101Neoplasm Metastasis 83Lung Neoplasms 72Carcinoma, Hepatocellular 71Pancreatic Neoplasms 67Breast Neoplasms 48Melanoma 44Carcinoma, Renal Cell 36Neoplasms 33Colorectal Neoplasms 26Squamous Cell Carcinoma of Head and Neck 25Glioblastoma 24Liver Neoplasms 20Head and Neck Neoplasms 16Small Cell Lung Carcinoma 15Sarcoma 13Glioma 12Kidney Neoplasms 11Urinary Bladder Neoplasms 9Recurrence 9Gliosarcoma 8Ovarian Neoplasms 7Adenocarcinoma of Lung 7Adenocarcinoma 7Prostate Cancer Metastatic 6Cholangiocarcinoma 6Central Nervous System Neoplasms 6Uveal Melanoma 5

Interventions

sintilimab 1lenvatinib 1Radiosurgery 1Oxaliplatin 1Mitomycin 1Gemcitabine 1Cryosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Liver Metastasis × Radiosurgery × Clear all
NCT00914615 2021-10-06

Stereotactic Body Radiation Therapy (SBRT) in Liver Metastasis (COLD 3)

University Health Network, Toronto

Phase 2 Completed
35 enrolled

Liver Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡